121 related articles for article (PubMed ID: 7200028)
21. Relationship between in vivo drug exposure of the tumor interstitium and inhibition of tumor cell growth in vitro: a study in breast cancer patients.
Müller M; Bockenheimer J; Zellenberg U; Klein N; Steger GG; Eichler HG; Mader RM
Breast Cancer Res Treat; 2000 Apr; 60(3):211-7. PubMed ID: 10930108
[TBL] [Abstract][Full Text] [Related]
22. Characterization of a cisplatin-resistant human ovarian carcinoma cell line expressing cross-resistance to 5-fluorouracil but collateral sensitivity to methotrexate.
Hill BT; Shellard SA; Hosking LK; Dempke WC; Fichtinger-Schepman AM; Tone T; Scanlon KJ; Whelan RD
Cancer Res; 1992 Jun; 52(11):3110-8. PubMed ID: 1591724
[TBL] [Abstract][Full Text] [Related]
23. Kinetic alterations induced by 5-fluorouracil in bone marrow, intestinal mucosa, and tumor.
Myers CE; Young RC; Chabner BA
Cancer Res; 1976 May; 36(5):1653-8. PubMed ID: 1268826
[TBL] [Abstract][Full Text] [Related]
24. Abnormal deoxyuridine suppression as a rapid predictor for antimetabolite chemosensitivity: correlation with in vitro tests of growth inhibition.
Block JB; Chlebowski RT; Dietrich MF; Isacoff WH
Cancer Treat Rep; 1984 Apr; 68(4):631-6. PubMed ID: 6538809
[TBL] [Abstract][Full Text] [Related]
25. Reduction of the anti-metabolic and anti-proliferative effects of methotrexate by 17 beta-oestradiol in a human breast carcinoma cell line, MDA-MB-436.
Clarke R; Van den Berg HW; Kennedy DG; Murphy RF
Eur J Cancer Clin Oncol; 1983 Jan; 19(1):19-24. PubMed ID: 6682774
[TBL] [Abstract][Full Text] [Related]
26. [Indication for antineoplastic agents (using 3H-thymidine)].
Fujimoto S; Miyoshi T; Watanabe Y; Watanuki S
Saishin Igaku; 1971 May; 26(5):997-9. PubMed ID: 5560176
[No Abstract] [Full Text] [Related]
27. Thymidine labeling index of human breast carcinoma. Enhancement of in vitro labeling by 5-fluorouracil and 5-fluoro-2'-deoxyuridine.
Meyer JS; Facher R
Cancer; 1977 Jun; 39(6):2524-32. PubMed ID: 141321
[TBL] [Abstract][Full Text] [Related]
28. On the poor correlation between the inhibition by methotrexate of dihydrofolate reductase and of deoxynucleoside incorporation into DNA.
Roberts D; Wodinsky I
Cancer Res; 1968 Oct; 28(10):1955-62. PubMed ID: 5696929
[No Abstract] [Full Text] [Related]
29. The mechanism of action of methotrexate in cultured L5178Y leukemia cells.
Hryniuk WM
Cancer Res; 1975 Apr; 35(4):1085-92. PubMed ID: 1054288
[TBL] [Abstract][Full Text] [Related]
30. Determination of rates of DNA synthesis in cultured mammalian cell populations.
Siegers MP; Schaer JC; Hirsiger H; Schindler R
J Cell Biol; 1974 Aug; 62(2):305-15. PubMed ID: 4214821
[TBL] [Abstract][Full Text] [Related]
31. Studies of variation in inherent sensitivities to radiation, 5-fluorouracil and methotrexate in a series of human and murine tumor cell lines in vitro.
Bellamy AS; Whelan RD; Hill BT
Int J Radiat Oncol Biol Phys; 1984 Jan; 10(1):87-93. PubMed ID: 6698828
[TBL] [Abstract][Full Text] [Related]
32. Assessment of growth-limiting events caused by 5-fluorouracil in mouse cells and in human cells.
Evans RM; Laskin JD; Hakala MT
Cancer Res; 1980 Nov; 40(11):4113-22. PubMed ID: 6162543
[No Abstract] [Full Text] [Related]
33. Dipyridamole potentiates the growth-inhibitory action of methotrexate and 5-fluorouracil in human keratinocytes in vitro.
Schwartz PM; Milstone LM
J Invest Dermatol; 1989 Oct; 93(4):523-7. PubMed ID: 2476512
[TBL] [Abstract][Full Text] [Related]
34. Methods for determining chemosensitivity of MCF-7 cells in double-layer agar culture: labeling index depression and colony count inhibition.
Elson DL; Osborne CK; Livingston RB; Von Hoff DD
Stem Cells (1981); 1982; 2(1):34-44. PubMed ID: 7157082
[TBL] [Abstract][Full Text] [Related]
35. Cytokinetic and cytotoxic effects of antimetabolites on 9L rat brain tumor cells in vitro.
Weizsaecker M; Hoshino T; Deen DF; Kobayashi S
Cancer Res; 1981 Oct; 41(10):3835-9. PubMed ID: 7284990
[TBL] [Abstract][Full Text] [Related]
36. [Attempts at synchronization of phase S with anticancer chemotherapy].
Duprez A; Bessot M
Bull Cancer; 1968; 55(1):75-86. PubMed ID: 5702313
[No Abstract] [Full Text] [Related]
37. Rate-limiting steps in the interactions of fluoropyrimidines and methotrexate.
Bowen D; Bailey BD; Guernsey LA
Eur J Cancer Clin Oncol; 1984 May; 20(5):651-7. PubMed ID: 6234172
[TBL] [Abstract][Full Text] [Related]
38. 5-Fluorouracil incorporation in DNA of human breast carcinoma cells.
Major PP; Egan E; Herrick D; Kufe DW
Cancer Res; 1982 Aug; 42(8):3005-9. PubMed ID: 6212116
[TBL] [Abstract][Full Text] [Related]
39. 5-Fluorouracil simultaneously maintains methotrexate antineoplastic activity in human breast cancer and protects against methotrexate cytotoxicity in human bone marrow.
Bowen D; Johnson DH; Southerland WM; Hughes DE; Hawkins M
Anticancer Res; 1999; 19(2A):985-8. PubMed ID: 10368642
[TBL] [Abstract][Full Text] [Related]
40. Effects of methotrexate on established cell lines of human choriocarcinoma.
Hussa RO; Pattillo RA
Eur J Cancer (1965); 1972 Oct; 8(5):523-9. PubMed ID: 4675660
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
